Loading resource…

Simone Fezzi, MD, MSC; Ashkan Yahyavi, MD; Bernardo Cortese, MD
The article reviews the evolution of dual antiplatelet therapy (DAPT) in the context of drug-eluting stents and its implications for patients undergoing PCI with drug-coated balloons. It highlights the challenges posed by prolonged DAPT in terms of bleeding risks and the potential benefits of shorter therapy durations in high bleeding risk (HBR) populations. The authors call for further research to address gaps in current understanding and treatment protocols, particularly for elderly patients and those with specific risk factors.
No account needed